Overview

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Status:
RECRUITING
Trial end date:
2027-03-30
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of GnRHa plus letrozole in obese progestin-insensitive EEC patients.
Phase:
PHASE2
Details
Lead Sponsor:
Xiaojun Chen
Treatments:
Letrozole
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-